Most stocks underperformed amid vaccine setback and economic data
Wall Street was mixed on Tuesday as the authorities halted the Johnson & Johnson vaccine's use after some recipients reported rare blood clots. On the other hand, the earnings season just started. USA30 fell 0.1%, while USA500 rose 0.42% closing at a new record high. TECH100 was up 1.16%.
Crude oil gained 0.6% reaching $60.05 per barrel.
Gold traded 0.3% lower at $1,726.95 per ounce.
Asia and Australia
Markets were up as investors awaited the US' consumer price index for March to see signs of an economic recovery.
HongKong45 rose 1.44% after the city's administration announced ease of the restrictive measures for those fully vaccinated against COVID-19.
Japan225 gained 1.04%.
Down under, Australia200 was up 0.01%.
Stocks traded in a mixed manner, focusing on the US inflation numbers and the UK's economic growth of 0.4%. The figures came below the 0.6% expected. Germany30 and France40 each gained 0.3%. UK100 dropped 0.2%.
Brent oil rose 0.7% to $63.69 a barrel.
EUR/USD traded 0.1% lower at 1.1902.
Sources: reuters.com, investing.com
This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.
You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.
This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com
JME Financial Services (Pty) Ltd trading as ZA.CAPEX.COM acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via ZA.CAPEX.COM, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15. Magnasale Trading Ltd is the principal to the CFD purchased by investors.